antibody MAb

Related by string. * ANTIBODY . Antibody : Affinity Optimized Antibody . Crucell rabies monoclonal antibody . antibody mediated rejection . antibody fragments . humanized monoclonal antibody / mAbs . MABS . MAB . MAbs . Med AB : monoclonal antibodies MAbs . WAM MAB . monoclonal antibodies mAbs . Butlers Plc MAB LN . Biosphere MAB * monoclonal antibody mAb . monoclonal antibody MAb *

Related by context. Frequent words. (Click for all words.) 73 forodesine 72 liposomal formulation 72 humanized monoclonal antibody 71 Epratuzumab 71 Panzem R 71 SAR# [004] 70 humanized antibody 70 human monoclonal antibody 70 MEK inhibitor 70 humanized anti 70 Irinotecan 70 pertuzumab 70 Cetrorelix 70 MORAb 69 IMC A# 69 Tesetaxel 69 relapsing multiple sclerosis 69 Pivotal Phase III 69 metastatic hormone refractory 69 ATL# [001] 69 human antibody therapeutics 69 Ixempra 69 multi kinase inhibitor 69 phase IIb clinical 69 Phase IIb trials 69 Ofatumumab 69 HGS ETR1 69 Metastatic Melanoma 69 relapsed multiple myeloma 69 Vandetanib 68 Adalimumab 68 Traficet EN 68 registrational trial 68 CYC# 68 angiogenesis inhibitor 68 orally bioavailable 68 relapsed refractory multiple myeloma 68 multiple myeloma MM 68 multicenter Phase 68 Pegasys ® 68 OncoVEX GM CSF 68 antisense drug 68 hypoxia inducible factor 68 anticancer compound 68 Allovectin 7 R 68 metastatic castration resistant 68 leukemia CLL 68 drug conjugate 68 Laquinimod 67 Onalta 67 Alemtuzumab 67 IIa trial 67 HER2 positive metastatic breast 67 immunomodulator 67 Amrubicin 67 Phase Ib clinical 67 KNS # 67 Gemzar ® 67 Initiates Phase 67 nab paclitaxel 67 PEG SN# 67 Pivotal Phase 67 gastrointestinal stromal tumors GIST 67 CR# vcMMAE 67 R sorafenib tablets 67 Diamyd ® 67 secondary hyperparathyroidism 67 hepatitis C HCV 67 CD# antibody [001] 67 ACZ# 67 Icatibant 67 Nexavar ® 67 HCV protease 67 enzastaurin 66 luteinizing hormone releasing 66 Monoclonal Antibody 66 Mipomersen 66 deforolimus 66 MKC# 66 elotuzumab 66 Cethromycin 66 thymalfasin 66 administered subcutaneously 66 phase IIa 66 metastatic renal cell carcinoma 66 diabetic neuropathic pain 66 Voreloxin 66 mRCC 66 superficial bladder cancer 66 Bortezomib 66 phase IIb 66 KRN# 66 Bavituximab 66 Phase III Clinical Trial 66 Dasatinib 66 Herceptin trastuzumab 66 BAY #-# 66 decitabine 66 biologic therapy 66 Diabetic Macular Edema 65 ocrelizumab

Back to home page